SEC EDGAR Filing Information

Form 6-K -- Report of foreign issuer [Rules 13a-16 and 15d-16]

Period of Report: 2008-05-29
Filing Date Changed: 2008-05-29
Documents: 6
SEC Accession No.
0001193125-08-124536
Filing date: 2008-05-29
Accepted: 2008-05-29 14:44:53

Table of submitted documents:

Seq Type Document Size Description
1 6-K d6k.htm 9507 FORM 6-K
2 EX-100.INS teva-20080512.xml 37316 XBRL INSTANCE DOCUMENT
3 EX-100.SCH teva-20080512.xsd 216131 XBRL TAXONOMY EXTENSION SCHEMA
4 EX-100.CAL teva-20080512_cal.xml 945286 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
5 EX-100.LAB teva-20080512_lab.xml 797410 XBRL TAXONOMY EXTENSION LABEL LINKBASE
6 EX-100.PRE teva-20080512_pre.xml 1483891 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
0001193125-08-124536.txt 3491797 Complete submission text file

Filer Information:

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) (0000818686)
IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 08866151
SIC: 2834 Pharmaceutical Preparations

  Assistant Director 1
Business Address
5 BAZEL ST
P O B 3190
PETACH TIKVA L3 49131
 Mailing Address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
5 BAZEL ST PO B 3190
PETACH TIKVA L3 49131